Table 1.

Characteristics of the study population at baseline Results shown as mean ± s.d. or median (percentile 5–95).

Age (years)	41.7 ± 12.0
Gender: women/total	105/136 (77%)
Active smokers	24/136 (17%)
Medical treatment duration (months)	18 (12.0–41.3)
Follow-up (months)	44 (12.0–185.3)
TPOAb+ at diagnosis	98/136 (72%)
TgAb+ at diagnosis	73/136 (54%)
TED	32/136 (23%)
Relapse	74/136 (54%)

TgAb+, positive for anti-Tg antibodies; TPOAb+; positive for anti-TPO antibodies; TED, thyroid eye disease.